The effect of Tranexamic Acid for bleeding in Spinal Surgery. Hemorrhagic condition, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Systemic tranexamic acid in first before the skin incision 10 mg per kg body weight as the initial bolus dose and then 1 mg per kg body weight every hour until the
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: Candidates to the spinal fixation surgery Agreed to participator
Exclusion criteria
Exclusion criteria: History of abnormal bleeding Platelet less than 150 thousands History of Thrombosis Consumption of interfering drugs with blood Homeostasis Overweight (BMI>30)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding. Timepoint: During surgery till 48 hours after surgery. Method of measurement: Number of pads and amount of suction blood during surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospitalization during laminectomy and in spinal fusion. Timepoint: During surgery and duration of hospitalization after surgery. Method of measurement: Duration of hospitalization in hospital days.;The amount of blood collected in hemovac in patients undergoing laminectomy and in spinal fusion. Timepoint: Duration of hospitalization after surgery. Method of measurement: The amount of blood accumulated in CC. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Farhad Mirzaei
Tabriz University of Medical Sciences
Outcome results
None listed